These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 1851068)

  • 1. Drug-induced Raynaud's phenomenon: beyond β-adrenoceptor blockers.
    Khouri C; Blaise S; Carpentier P; Villier C; Cracowski JL; Roustit M
    Br J Clin Pharmacol; 2016 Jul; 82(1):6-16. PubMed ID: 26949933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying digital vascular disease in patients with primary Raynaud's phenomenon and systemic sclerosis.
    Herrick AL; Clark S
    Ann Rheum Dis; 1998 Feb; 57(2):70-8. PubMed ID: 9613334
    [No Abstract]   [Full Text] [Related]  

  • 3. Vascular and humoral sympathetic nervous system reactivity during mental arithmetic in primary Raynaud's phenomenon.
    Droste H; Wollersheim H; Reyenga J; Thien T
    Int Angiol; 1990; 9(2):84-9. PubMed ID: 2254680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of digital artery adrenoceptors in Raynaud's disease.
    Cooke JP; Creager SJ; Scales KM; Ren C; Tsapatsaris NP; Beetham WP; Creager MA
    Vasc Med; 1997; 2(1):1-7. PubMed ID: 9546943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-adrenergic receptors in platelets from patients with Raynaud's syndrome.
    Keenan EJ; Porter JM
    Surgery; 1983 Aug; 94(2):204-9. PubMed ID: 6308842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenoceptors in Raynaud's disease.
    Lindblad LE; Ekenvall L; Etzell BM; Bevegård S
    J Cardiovasc Pharmacol; 1989 Dec; 14(6):881-5. PubMed ID: 2481777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raynaud's phenomenon: peripheral catecholamine concentration and effect of sympathectomy.
    Nielsen SL; Christensen NJ; Olsen N; Lassen NA
    Acta Chir Scand Suppl; 1980; 502():57-62. PubMed ID: 6941602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenoceptors on blood cells from patients with primary Raynaud's phenomenon.
    Graafsma SJ; Wollersheim H; Droste HT; ten Dam MA; van Tits LJ; Reyenga J; Rodrigues de Miranda JF; Thien T
    Clin Sci (Lond); 1991 Apr; 80(4):325-31. PubMed ID: 1851068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of Raynaud's disease.
    Cooke JP; Marshall JM
    Vasc Med; 2005 Nov; 10(4):293-307. PubMed ID: 16444858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raynaud's phenomenon. An update.
    Coffman JD
    Hypertension; 1991 May; 17(5):593-602. PubMed ID: 2022404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of Raynaud's phenomenon.
    Herrick AL
    Rheumatology (Oxford); 2005 May; 44(5):587-96. PubMed ID: 15741200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Calcium antagonists and Raynaud's phenomenon].
    Hachulla E; Devulder B
    Therapie; 1993; 48 Spec No():707-11. PubMed ID: 8091357
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.